VPASIA Performance — ProFund VP Asia 30
Data updated: 2026-08-28
VPASIA returned +3.16% year to date and +12.87% over one year to Jun 2026. Annualised returns are +13.67% over 3 years and −4.04% over 5 years. The fund trailed its Asia-Pacific Equity category average: $100 invested three years ago grew to $147, against $172 for the category, and to $113 over one year, against $137. Volatility over the past three years was 21.91% a year. In the 12 months to Jun 2026 the fund took in a net $2.4M, and assets reached $22.52M.
VPASIA Growth of $100
What $100 invested in ProFund VP Asia 30 grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Asia-Pacific Equity category average over the same months.
| Period | VPASIA | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $113 | $137 |
| 3 years (Jul 2023 – Jun 2026) | $147 | $172 |
| 5 years (Jul 2021 – Jun 2026) | $81 | $136 |
| Since data start (Jul 2019 – Jun 2026) | $136 | $192 |
VPASIA Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +3.16% |
| 1 year | +12.87% |
| 3 years (annualised) | +13.67% |
| 5 years (annualised) | −4.04% |
VPASIA Annual Returns
Calendar-year total returns of ProFund VP Asia 30, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +3.16% |
| 2025 | +24.12% |
| 2024 | +11.55% |
| 2023 | +4.32% |
| 2022 | −24.42% |
| 2021 | −18.52% |
| 2020 | +35.54% |
| 2019 (Jul–Dec) | +9.15% |
VPASIA Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.3% | −2.1% | −10.2% | +9.8% | +3.8% | +0.7% | — | — | — | — | — | — |
| 2025 | +2.9% | +5.2% | +0.4% | −5.0% | +4.6% | +5.1% | +2.8% | +7.6% | +7.2% | +0.1% | −6.6% | −1.3% |
| 2024 | −11.1% | +8.6% | +2.4% | +1.7% | +4.6% | −1.6% | −2.0% | −0.5% | +18.5% | −3.7% | −2.5% | −0.7% |
| 2023 | +15.9% | −9.6% | +6.1% | −9.4% | −6.5% | +7.7% | +13.0% | −10.0% | −4.8% | −4.0% | +6.8% | +3.5% |
| 2022 | −4.8% | −4.2% | −10.6% | −7.0% | +2.9% | +9.6% | −7.1% | +2.6% | −17.5% | −14.8% | +35.3% | −2.5% |
| 2021 | +15.7% | +8.8% | −10.9% | +0.5% | −2.7% | +2.9% | −13.4% | +0.3% | −6.0% | +1.2% | −4.8% | −8.1% |
| 2020 | −5.6% | −3.2% | −12.8% | +9.6% | +3.8% | +10.3% | +8.3% | +6.8% | −1.4% | +2.1% | +8.2% | +7.6% |
| 2019 | — | — | — | — | — | — | −1.5% | −3.2% | −0.3% | +4.5% | +3.9% | +5.8% |
VPASIA Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 21.91%
- 3-year Sharpe ratio: 0.42 (vs 4.5% risk-free rate)
- Best month: +18.54% (Sep 2024)
- Worst month: −11.05% (Jan 2024)
VPASIA Fund Flows
Monthly money in and out of ProFund VP Asia 30, from SEC Form N-PORT.
- 12-month net flow: $2.4M
- 12-month gross sales (incl. reinvestments): $41.7M
- Sales ÷ redemptions: 1.06×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $1.6M | $2.1M | −$448K |
| May 2026 | $1.4M | $2.3M | −$914K |
| Apr 2026 | $4.2M | $1.4M | $2.8M |
| Mar 2026 | $2.1M | $2.1M | −$9K |
| Feb 2026 | $2.2M | $1.3M | $948K |
| Jan 2026 | $2.4M | $2.2M | $180K |
| Dec 2025 | $4.1M | $5.5M | −$1.4M |
| Nov 2025 | $3.9M | $4.0M | −$166K |
| Oct 2025 | $7.0M | $7.9M | −$915K |
| Sep 2025 | $5.7M | $4.5M | $1.2M |
| Aug 2025 | $6.6M | $5.2M | $1.3M |
| Jul 2025 | $515K | $777K | −$262K |
VPASIA Assets Under Management
Net assets of ProFund VP Asia 30 by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $22.52M |
| 2026-03-31 | $18.22M |
| 2025-12-31 | $19.23M |
| 2025-09-30 | $23.41M |
| 2025-06-30 | $18.53M |
| 2025-03-31 | $19.50M |
| 2024-12-31 | $16.22M |
| 2024-09-30 | $16.62M |
| 2024-06-30 | $16.33M |
| 2024-03-31 | $14.74M |
| 2023-12-31 | $15.28M |
| 2023-09-30 | $14.85M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.